Effects of humoral immunity and calreticulin overexpression on postoperative course in breast cancer.
D000917:Antibody Formation / Q000502:physiology*; D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000276:immunology* / Q000378:metabolism* / Q000601:surgery; D037282:Calreticulin / Q000378:metabolism*; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D008207:Lymphatic Metastasis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism
D014408:Biomarkers, Tumor; D037282:Calreticulin; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human